Status:
RECRUITING
SERum-bank for PANcreatic Cancer
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Adenocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study is about pancreatic cancer. If the diagnostic cancer is done at an early stage (\<2cm), the chances of recovery are very good. But the main problem is there is not any detections means for...
Detailed Description
The purpose of this study is to establish a sero-library in a case-control cohort to assess several potentially useful serum biomarkers, such as adiponectin in the early diagnosis of pancreatic cancer...
Eligibility Criteria
Inclusion
- ADENOCARCINOMA GROUP
- Documented adenocarcinoma (cytology / anatomopathology), all stages, except if the tumor is immediately resectable and does not require preoperative cytological evidence. In this case, the inclusion and the first collection of the sero bank is done preoperatively. The diagnostic confirmation will therefore be made post-operatively at the risk of being excluded in the event of a different diagnosis.
- At the start of treatment (before surgery / 1st course of chemotherapy)
- Age ≥ 18 years
- Patient affiliated or entitled to a social security system
Exclusion
- Patient refusal
- Acute renal failure
- Child-Pugh B or C cirrhosis
- Patient under guardianship or curators
- Other synchronous cancer or history of cancer \<5 years
- Language barrier
- CONTROL GROUP
- Inclusion Criteria:
- Age ≥ 40 years
- Patient affiliated or entitled to a social security system
- Digestive endoscopy for any reason other than cancer or chronic inflammatory bowel disease
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04374175
Start Date
April 1 2020
End Date
January 1 2026
Last Update
March 18 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Saint-Etienne
Saint-Etienne, France
2
Institut Cancérologique Lucien Newirth (ICLN)
Saint-Priest-en-Jarez, France, 42270